Movement Disorder

Movement disorders are neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness, paralysis of spasticity of the muscles. They affect the speed, fluency or smoothness, quality, and ease of movement.
What are Movement Disorders?

Movement, although seemingly simple like picking up a bit of paper, is actually a complex process that requires activities of several different parts of the brain working in tandem with muscles and nerves.

Read More

Overview

Feature Articles

Latest Movement Disorder News and Research

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Emotional bodily sensations altered in Parkinson's disease

Emotional bodily sensations altered in Parkinson's disease

Gut microbiome shows no clear link to cognitive impairments in Parkinson's disease

Gut microbiome shows no clear link to cognitive impairments in Parkinson's disease

Study shows cellular, molecular overlaps in ALS and FTLD

Study shows cellular, molecular overlaps in ALS and FTLD

Skin biopsy test shows promise in diagnosing Parkinson's disease and synucleinopathies

Skin biopsy test shows promise in diagnosing Parkinson's disease and synucleinopathies

Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms

Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms

Essential tremor associated with increased risk of dementia

Essential tremor associated with increased risk of dementia

Diets impact Parkinson's motor symptoms, supplements show no benefit, study finds

Diets impact Parkinson's motor symptoms, supplements show no benefit, study finds

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Rucaparib and its major metabolite exhibit differential biological activity and synergy

Words matter: Delivering Parkinson's diagnosis with empathy and hope

Words matter: Delivering Parkinson's diagnosis with empathy and hope

Study uncovers vast genomic diversity in Aboriginal Australian communities

Study uncovers vast genomic diversity in Aboriginal Australian communities

Transforming brain research with AI and machine learning

Transforming brain research with AI and machine learning

Game-changer for Parkinson’s therapy: Innovative neuroprosthesis enhances mobility and balance

Game-changer for Parkinson’s therapy: Innovative neuroprosthesis enhances mobility and balance

Wearable devices and machine learning revolutionize Parkinson's disease monitoring

Wearable devices and machine learning revolutionize Parkinson's disease monitoring

Does caffeine interact with genetic risk factors for Parkinson's disease in Asians?

Does caffeine interact with genetic risk factors for Parkinson's disease in Asians?

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

New blood test pinpoints Parkinson's disease through mitochondrial DNA damage

Could AI be the game-changer in remote Parkinson's diagnosis?

Could AI be the game-changer in remote Parkinson's diagnosis?

Study finds examining retinal structure could provide markers for Parkinson disease

Study finds examining retinal structure could provide markers for Parkinson disease

UVA Health launches clinical trial to determine if focused ultrasound can help people quit cocaine

UVA Health launches clinical trial to determine if focused ultrasound can help people quit cocaine

Early hallucinations may indicate faster cognitive decline in patients with Parkinson's disease

Early hallucinations may indicate faster cognitive decline in patients with Parkinson's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.